ICON Clinical Research Limited
ICON Clinical Research Limited, headquartered in Ireland (IE), is a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1990, ICON has established itself as a trusted partner in clinical research, with a strong presence across Europe, North America, and Asia-Pacific.
The company offers a comprehensive range of services, including clinical trial management, data management, and regulatory affairs, distinguished by its commitment to innovation and quality. ICON's unique approach integrates advanced technology and deep therapeutic expertise, enabling clients to navigate the complexities of clinical development efficiently.
Recognised for its market leadership, ICON has achieved numerous accolades, reflecting its dedication to excellence and client satisfaction. With a robust portfolio and a focus on delivering results, ICON Clinical Research Limited continues to shape the future of clinical trials globally.
+42 vs industry average
ICON Clinical Research Limited’s score of 72 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at ICON Clinical Research Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has reduced its overall emissions by 20% since 2018
Reported emissions
No reported emissions data is available for ICON Clinical Research Limited yet.
ICON Clinical Research Limited's reported carbon emissions
ICON Clinical Research Limited, headquartered in Ireland (IE), currently does not report specific carbon emissions data for the most recent year. As a current subsidiary of ICON Public Limited Company, any emissions data or climate commitments would be inherited from this parent organization.
ICON Public Limited Company has established various climate initiatives, including commitments to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for ICON Clinical Research Limited are not detailed in the available information.
As part of its corporate family, ICON Clinical Research Limited aligns with broader industry standards and practices aimed at reducing carbon footprints and enhancing sustainability. The absence of specific emissions data highlights the need for ongoing transparency and commitment to climate action within the organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
ICON Clinical Research Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for ICON Clinical Research Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from ICON Public Limited Company
Carbon Disclosure Project
Inherited from ICON Public Limited CompanyThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from ICON Public Limited CompanyRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project